Professor Martina Brueckmann
Offenbach (Germany)
Follow
Contributor content
Journal
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
7 December 2022
Journal
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
18 October 2022
Journal
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
8 December 2021
Journal
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial
23 August 2021
Journal
Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial
29 June 2021
Journal
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
9 January 2021
